Identification of Proinflammatory Flagellin Proteins in Supernatants of Vibrio cholerae O1 by Proteomics Analysis*S

The genome of Vibrio cholerae contains five flagellin genes that encode proteins (FlaA–E) of 39–41 kDa with 61–82% identity among them. Although the existing live oral attenuated vaccine strains against cholera are protective in humans, there is an intrinsic residual cytotoxic and inflammatory component associated with these candidate vaccine strains. Bacterial flagellins are known to be potent inducers of proinflammatory molecules via activation of Toll-like receptor 5. Here we found that purified flagella from wild type V. cholerae 395 induced significant release of interleukin (IL)-8 from cultured HT-29 human colonic epithelial cells. Furthermore we found that filtered supernatants of KKV90, a ΔflaA isogenic strain unable to produce flagella, were still able to activate production of IL-8 albeit to significantly lower levels than the wild type, suggesting that other activators of proinflammatory molecules were still present in these supernatants. A comparative proteomics analysis of secreted proteins of V. cholerae 395 and KKV90 identified additional proteins with potential to induce IL-8 release in HT-29 cells. Secreted proteins in the range of 30–45 kDa identified by two-dimensional electrophoresis and mass spectrometry revealed the presence of two additional flagellins, FlaC and FlaD, that appeared to be secreted 3- and 6-fold more, respectively, in the mutant compared with the wild type. Double isogenic mutants flaAC and flaAD were unable to trigger IL-8 release from HT-29 cells. In sum, we have shown that purified flagella and secreted flagellin proteins (FlaC and FlaD) are inducers of IL-8 release from epithelial cells via Toll-like receptor 5. This observation may explain, in part, the observed reactogenicity of cholera vaccine strains in humans.

[1]  S. Akira,et al.  Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.

[2]  N. Subramanian,et al.  Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella , 2006, Nature Immunology.

[3]  J. Holmgren,et al.  Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea. , 2005, Current opinion in immunology.

[4]  A. Talavera,et al.  The Vaccine Candidate Vibrio cholerae 638 Is Protective against Cholera in Healthy Volunteers , 2005, Infection and Immunity.

[5]  J. Kaper,et al.  Induction of Interleukin-8 in T84 Cells by Vibrio cholerae , 2004, Infection and Immunity.

[6]  S. Mizel,et al.  Induction of Macrophage Nitric Oxide Production by Gram-Negative Flagellin Involves Signaling Via Heteromeric Toll-Like Receptor 5/Toll-Like Receptor 4 Complexes1 , 2003, The Journal of Immunology.

[7]  P. Sansonetti,et al.  The Contribution of Accessory Toxins of Vibrio cholerae O1 El Tor to the Proinflammatory Response in a Murine Pulmonary Cholera Model , 2002, The Journal of experimental medicine.

[8]  A. Torres,et al.  The flagella of enteropathogenic Escherichia coli mediate adherence to epithelial cells , 2002, Molecular microbiology.

[9]  C. Wennerås,et al.  Increased Levels of Inflammatory Mediators in Children and Adults Infected with Vibrio cholerae O1 and O139 , 2002, Clinical and Vaccine Immunology.

[10]  Shizuo Akira,et al.  Toll-like receptors as adjuvant receptors. , 2002, Biochimica et biophysica acta.

[11]  A. Delcour,et al.  Vibrio cholerae OmpU and OmpT Porins Are Differentially Affected by Bile , 2002, Infection and Immunity.

[12]  L. McCarter Polar Flagellar Motility of theVibrionaceae , 2001, Microbiology and Molecular Biology Reviews.

[13]  P. Godowski,et al.  Cutting Edge: Bacterial Flagellin Activates Basolaterally Expressed TLR5 to Induce Epithelial Proinflammatory Gene Expression1 , 2001, The Journal of Immunology.

[14]  J. Mekalanos,et al.  Vibrio cholerae tolC Is Required for Bile Resistance and Colonization , 2001, Infection and Immunity.

[15]  N. Caroff,et al.  Nontoxigenic Vibrio Cholerae O1 Bacteremia: Case Report and Review , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[16]  M. Waldor,et al.  Regulation and Temporal Expression Patterns of Vibrio cholerae Virulence Genes during Infection , 1999, Cell.

[17]  R. Clayton,et al.  Identification of a vibrio cholerae RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Anisia J. Silva,et al.  Preliminary Assessment of the Safety and Immunogenicity of a New CTXΦ-Negative, Hemagglutinin/Protease-Defective El Tor Strain as a Cholera Vaccine Candidate , 1999, Infection and Immunity.

[19]  J. Madara,et al.  Orchestration of Neutrophil Movement by Intestinal Epithelial Cells in Response to Salmonella typhimurium Can Be Uncoupled from Bacterial Internalization , 1999, Infection and Immunity.

[20]  V. DiRita,et al.  Analysis of ToxR‐dependent transcription activation of ompU, the gene encoding a major envelope protein in Vibrio cholerae , 1998, Molecular microbiology.

[21]  T. Wassenaar,et al.  Mode of primary binding to target membranes and pore formation induced by Vibrio cholerae cytolysin (hemolysin). , 1997, European journal of biochemistry.

[22]  T. Postnova,et al.  Motility mutants of Vibrio cholerae O1 have reduced adherence in vitro to human small intestinal epithelial cells as demonstrated by ELISA. , 1996, Microbiology.

[23]  D. Milton,et al.  Identification and characterization of additional flagellin genes from Vibrio anguillarum , 1996, Journal of bacteriology.

[24]  Matthew K. Waldor,et al.  Lysogenic Conversion by a Filamentous Phage Encoding Cholera Toxin , 1996, Science.

[25]  J. Mekalanos,et al.  Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression , 1996, Infection and immunity.

[26]  C. Tacket,et al.  New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae , 1996, Infection and immunity.

[27]  V. Sperandio,et al.  The OmpU outer membrane protein, a potential adherence factor of Vibrio cholerae , 1995, Infection and immunity.

[28]  D. Spriggs,et al.  Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. , 1995, The Journal of infectious diseases.

[29]  M. Mathan,et al.  Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. , 1995, Gastroenterology.

[30]  L. McCarter Genetic and molecular characterization of the polar flagellum of Vibrio parahaemolyticus , 1995, Journal of bacteriology.

[31]  J. Ezzell,et al.  Development of a live, oral, attenuated vaccine against El Tor cholera. , 1994, The Journal of infectious diseases.

[32]  J. Mekalanos,et al.  Cholera vaccines: fighting an ancient scourge. , 1994, Science.

[33]  M. Levine,et al.  Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. , 1993, The Journal of infectious diseases.

[34]  J. Kaper,et al.  Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. Mayrhofer,et al.  Amino-terminal domain of the El Tor haemolysin of Vibrio cholerae O1 is expressed in classical strains and is cytotoxic. , 1991, Vaccine.

[36]  K. Richardson Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models , 1991, Infection and immunity.

[37]  J. Kaper,et al.  Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Mekalanos,et al.  Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation , 1991, Cell.

[39]  D. Sack,et al.  Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines. , 1990, Vaccine.

[40]  C. Tacket,et al.  SAFETY, IMMUNOGENICITY, AND EFFICACY OF RECOMBINANT LIVE ORAL CHOLERA VACCINES, CVD 103 AND CVD 103-HgR , 1988, The Lancet.

[41]  M. Levine,et al.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques , 1988, Infection and immunity.

[42]  V. L. Miller,et al.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  K. Richardson,et al.  Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane , 1985, Infection and immunity.

[44]  V. L. Miller,et al.  Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Attridge,et al.  The role of the flagellum in the adherence of Vibrio cholerae. , 1983, The Journal of infectious diseases.

[46]  R. Finkelstein,et al.  Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Freter,et al.  Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice , 1981, Infection and immunity.

[48]  R. Peto THE HORSE-RACING EFFECT , 1981, The Lancet.

[49]  L. Cisneros,et al.  Duration of infection-derived immunity to cholera. , 1981, The Journal of infectious diseases.

[50]  A. D. Larson,et al.  Characterization of a flagellar sheath protein of Vibrio cholerae , 1980, Infection and immunity.

[51]  P. O’Farrell High resolution two-dimensional electrophoresis of proteins. , 1975, The Journal of biological chemistry.

[52]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[53]  J. Girón Role of Flagella in Mucosal Colonization , 2005 .

[54]  J. Mekalanos,et al.  Copyright © 1998, American Society for Microbiology Differential Regulation of Multiple Flagellins in Vibrio cholerae , 1997 .

[55]  P. Blake,et al.  Diseases of humans (other than cholera) caused by vibrios. , 1980, Annual review of microbiology.

[56]  R. Yancey,et al.  Motility of the pathogen and intestinal immunity of the host in experimental cholera. , 1978, Advances in experimental medicine and biology.

[57]  B. Finlay,et al.  Copyright © 1997, American Society for Microbiology Common Themes in Microbial Pathogenicity Revisited , 2022 .